2
Announcements
Trials
Browse
Landscape
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Observational
1
Sponsor
Conditions
Disease
3
Prostatic Neoplasms
2
Hereditary Cancer
2
Colorectal Neoplasms
2
Sarcoma, Kaposi
1
Precursor Cell Lymphoblastic Leukemia-Lymphoma
1
Pain
1
Neoplasms
1
Lung Neoplasms
1
Gynecologic Cancer
1
Genetic Diseases, Inborn
1
Development of the Virtual Biopsy
1
Colorectal Neoplasms, Hereditary Nonpolyposis
1
Colonic Neoplasms
1
Chronic Pain
1
Castleman Disease
1
Cancer Pain
1
COVID-19
1
Breast Neoplasms
1
Brain Neoplasms
1
Anus Neoplasms
1
Adenoma
1
Interventions
Morphine
7
Surveys and Questionnaires
6
Ketamine
5
Fentanyl
4
Sodium Chloride
3
Saline Solution
3
Lidocaine
3
Educational Status
3
Dexmedetomidine
3
Cognitive Behavioral Therapy
3
Anesthetics, Local
3
ziconotide
2
Pregabalin
2
Mindfulness-Based Stress Reduction
2
Hypnosis
2
Control Groups
2
Bupivacaine
2
Acetaminophen
2
6'-fluoro-4',9'-dihydro-N,N-dimethyl-4-phenylspiro(cyclohexane-1,1'(3'H)-pyrano(3,4-b)indol)-4-amine
2
tianeptine
1
siltuximab
1
onabotulinum toxin A
1
nabiximols
1
morphine, naltrexone combination
1
erenumab
1
Yoga
1
Waiting Lists
1
Transcutaneous Electric Nerve Stimulation
1
Tramadol
1
Therapeutics
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Chronic Pain
×
Diagnostic Tests, Routine
×
Clear all
NCT03981809
2023-08-22
PainsCan
Universitaire Ziekenhuizen KU Leuven
Completed
92 enrolled